These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9874415)

  • 1. American Cancer Society Lymphedema Workshop. Workgroup I: Treatment of the axilla with surgery and radiation--preoperative and postoperative risk assessment.
    Leitch AM; Meek AG; Smith RA; Boris M; Bourgeois P; Higgins S; Pressman PI; Stevens J; Stevens RE
    Cancer; 1998 Dec; 83(12 Suppl American):2877-9. PubMed ID: 9874415
    [No Abstract]   [Full Text] [Related]  

  • 2. American Cancer Society Lymphedema Workshop. Workgroup II: Patient education--pre-and posttreatment.
    Runowicz CD; Passik SD; Hann D; Berson A; Chang H; Makar K; Moss R; Osuch J; Petrek JD; Vaillant-Newman AM
    Cancer; 1998 Dec; 83(12 Suppl American):2880-1. PubMed ID: 9874416
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of sentinel lymph node biopsy on lymphedema following breast cancer treatment.
    Soran A; Aydin C; Harlak A; Vogel VG; Johnson R
    Breast J; 2005; 11(5):370-1. PubMed ID: 16174167
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphedema in breast cancer patients: declining, but awareness still needed.
    J Support Oncol; 2006 Feb; 4(2):71. PubMed ID: 16499122
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of secondary lymphedema.
    Pissas A; Rzal K; Math ML; el Nasser M; Dubois JB
    Ann Ital Chir; 2002; 73(5):489-92. PubMed ID: 12704988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precipitating factors for lymphedema following surgical treatment of breast cancer: implications for patients undergoing axillary lymph node dissection.
    Dayangac M; Makay O; Yeniay L; Aynaci M; Kapkac M; Yilmaz R
    Breast J; 2009; 15(2):210-1. PubMed ID: 19292814
    [No Abstract]   [Full Text] [Related]  

  • 7. Axillary conservation in early breast cancer.
    Dodwell D; Goyal A
    Br J Surg; 2015 Oct; 102(11):1297-9. PubMed ID: 26148870
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
    Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
    Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supraclavicular radiotherapy and lymphedema risk.
    Graham PH
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1627. PubMed ID: 19616750
    [No Abstract]   [Full Text] [Related]  

  • 11. Development and Validation of a Nomogram to Predict Lymphedema After Axillary Surgery and Radiation Therapy in Women With Breast Cancer From the NCIC CTG MA.20 Randomized Trial.
    Gross JP; Whelan TJ; Parulekar WR; Chen BE; Rademaker AW; Helenowski IB; Donnelly ED; Strauss JB
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):165-173. PubMed ID: 31085285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
    Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
    Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
    McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
    J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disability and lymphedema].
    Boccardo F; Campisi C
    Ann Ital Chir; 2002; 73(5):485-8. PubMed ID: 12704987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Axillary reverse mapping--chance to prevent lymphedema in breast cancer patients].
    Pavlista D; Koliba P; Eliska O
    Ceska Gynekol; 2011 Oct; 76(5):355-9. PubMed ID: 22132635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lanreotide Autogel 90 mg and lymphorrhea prevention after axillary node dissection in breast cancer: a phase III double blind, randomized, placebo-controlled trial.
    Gauthier T; Garuchet-Bigot A; Marin B; Mollard J; Loum O; Fermeaux V; Jammet I; Kanoun D; Maubon A; Aubard Y
    Eur J Surg Oncol; 2012 Oct; 38(10):902-9. PubMed ID: 22703757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
    Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
    Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphedema and exercise.
    Hock K
    Oncol Nurs Forum; 1998 Sep; 25(8):1310. PubMed ID: 9766280
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphedema following axillary lymph node dissection for breast cancer.
    Sakorafas GH; Peros G; Cataliotti L; Vlastos G
    Surg Oncol; 2006 Nov; 15(3):153-65. PubMed ID: 17187979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axillary dissection for breast cancer.
    Olszewski WL
    Lymphology; 2002 Mar; 35(1):41-2. PubMed ID: 11939573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.